Cardiac Surgery Clinical Trial
— RECAPOfficial title:
Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Physiologic Study (RECAP)
Verified date | July 2014 |
Source | Duke University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage
Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS
study randomizes cardiac surgery patients to receive either red blood cell units stored for
no more than 10 days, or red blood cell units stored for at least 21 days, if they need any
red blood cell transfusions during their hospital stay for the surgery.
This ancillary study is entitled Impact of Blood Storage Duration on Physiologic Measures:
RECESS Ancillary Physiologic Study (RECAP). The hypothesis of the RECAP study is that there
will be differences between the two randomized treatment groups in how much the following
measurements change, from shortly before a red blood cell transfusion to shortly after a red
blood cell transfusion, and from before surgery to 24 hours after surgery:
- Oxygen saturation in the hand
- Oxygen saturation in the brain
- Blood flow in the small blood vessels under the tongue.
The RECAP study will also investigate whether changes in the measurements listed above are
associated with clinical outcomes, including
- The Multi-Organ Dysfunction Score
- Death from any cause
- Major cardiac events
- Major pulmonary events
Status | Completed |
Enrollment | 390 |
Est. completion date | January 2014 |
Est. primary completion date | January 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Eligible and randomized in the RECESS study (NCT00991341) - At least 18 years old - Willing to comply with protocol and provide written informed consent for both RECESS and RECAP - Scheduled to undergo coronary artery bypass (CABG), valve, or combined CABG plus valve surgery Exclusion Criteria: - Prior randomization into the RECESS or RECAP studies - Undergoing off-pump cardiac surgery - Undergoing a significant concomitant surgical procedure - Known sickle cell disease - Participation in a clinical trial (except observational studies or RECESS) within the previous 30 days - Received any investigational product within prior 30 days - Not able to be randomized in RECESS |
Country | Name | City | State |
---|---|---|---|
United States | Brigham and Womens Hospital | Boston | Massachusetts |
United States | Massachusetts General Hospital | Boston | Massachusetts |
United States | Duke University Medical Center | Durham | North Carolina |
United States | University of Minnesota | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Duke University | National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Stowell CP, Whitman G, Granger S, Gomez H, Assmann SF, Massey MJ, Shapiro NI, Steiner ME, Bennett-Guerrero E. The impact of red blood cell storage duration on tissue oxygenation in cardiac surgery. J Thorac Cardiovasc Surg. 2016 Nov 19. pii: S0022-5223(16 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in thenar oxygenation saturation | From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion. | ||
Secondary | Change in downslope of thenar oxygen saturation | From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion. | ||
Secondary | Change in upslope of thenar oxygen saturation | From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion. | ||
Secondary | Change in cerebral oxygenation | From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion. | ||
Secondary | Change in microvascular mean flow index | From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion. | ||
Secondary | Change in percent perfused vessels | From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion. | ||
Secondary | Change in capillary density index | From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion. | ||
Secondary | Change in thenar oxygen saturation | From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery | ||
Secondary | Change in downslope of thenar oxygen saturation | From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery | ||
Secondary | Change in upslope of thenar oxygen saturation | From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery | ||
Secondary | Change in cerebral oxygenation | From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery | ||
Secondary | Change in microvascular mean flow index | From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery | ||
Secondary | Change in percent perfused vessels | From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery | ||
Secondary | Change in capillary density index | From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery | ||
Secondary | Change in multi-organ dysfunction score | From pre-surgery baseline to post-operative Day 7, hospital discharge, or death, whichever occurs first | ||
Secondary | All-cause mortality | Through post-operative Day 28 | ||
Secondary | Composite of major cardiac events | Through post-operative Day 7, hospital discharge, or death, whichever occurs first | ||
Secondary | Composite of major pulmonary events | Through post-operative Day 7, hospital discharge, or death, whichever occurs first |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054179 -
Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04051021 -
Non-Pharmacological Interventions on Patient Experience and Healthcare Utilization in Adult Cardiac Surgery Patients
|
N/A | |
Recruiting |
NCT04604886 -
The Consistency of Cardiac Output Measured by Pulmonary Artery Catheter and LiDCO in Cardiac Surgical Patients
|
N/A | |
Recruiting |
NCT04075981 -
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
|
Phase 3 | |
Completed |
NCT04062396 -
Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction
|
N/A | |
Recruiting |
NCT04709705 -
DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05563662 -
SURgical Registry of ENDocarditis EuRope
|
||
Withdrawn |
NCT03289104 -
Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX
|
N/A | |
Completed |
NCT04199039 -
Effects of Endotracheal Tube Fixation Methods on Hemodynamic Parameters During Endotracheal Suction
|
N/A | |
Completed |
NCT03563196 -
Diagnosis Of Pulmonary Complications After Cardiac Surgery In Children
|
||
Completed |
NCT02964026 -
Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients
|
N/A | |
Completed |
NCT02471001 -
The Levels of Anaesthetics in Heart Muscle During Heart Surgery
|
N/A | |
Completed |
NCT02325726 -
RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.
|
N/A | |
Completed |
NCT01246947 -
Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation
|
N/A | |
Completed |
NCT01151254 -
Comparison of Propofol Based Versus Volatile Based Anesthesia and Postoperative Sedation
|
N/A | |
Completed |
NCT00996099 -
Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients
|
N/A | |
Completed |
NCT00821262 -
Sevoflurane in Cardiac Surgery
|
Phase 4 | |
Completed |
NCT00617955 -
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
|
N/A | |
Completed |
NCT00337805 -
Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery
|
Phase 2/Phase 3 | |
Completed |
NCT00336466 -
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)
|
Phase 2 |